Create

Sign in to ReadmeX

or

How we handle your data: Privacy Policy

ReadmeX

Your AI reading companion

What would you like to catch up on?

Pick a briefing, or ask your own question.

Your community and people briefings stay personal to you.

Story

OpenAI Collaborates on GPT-Rosalind Brain Research

AI summary

OpenAI presented GPT-Rosalind in work with PerturbAI and Scripps Research on brain research and neurodegenerative diseases. OpenAI says the system helps scientists identify new leads for understanding and treating these diseases, but the supplied report provides no supporting research details or independent validation.

In-depth insight

The collaboration connects GPT-Rosalind with brain research focused on neurodegenerative diseases, while its claimed scientific benefits remain an OpenAI assertion without independent validation in the supplied report.

GPT-Rosalind for new leads for understanding and treating neurodegenerative diseases: https://twitter.com/OpenAI/status/2123899406550528422

@OpenAI: How AI is helping scientists uncover new leads for understanding and treating neurodegenerative diseases—and the brain research behind our collaboration with @perturbai_tx and @scrippsresearch: https://x.com/OpenAI/status/2123899406550528422/video/1 https://twitter.com/OpenAI/status/2112899854569762936 https://x.com/OpenAI/status/2123899406550528422

#OpenAI#GPT-Rosalind#PerturbAI#Scripps Research

Original · 1 min readRead the original
Group chat

No comments yet. Start the conversation.